GB0517386D0 - Combinations for the treatment of cancer - Google Patents
Combinations for the treatment of cancerInfo
- Publication number
- GB0517386D0 GB0517386D0 GB0517386A GB0517386A GB0517386D0 GB 0517386 D0 GB0517386 D0 GB 0517386D0 GB 0517386 A GB0517386 A GB 0517386A GB 0517386 A GB0517386 A GB 0517386A GB 0517386 D0 GB0517386 D0 GB 0517386D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer
- combinations
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0517386A GB0517386D0 (en) | 2005-08-26 | 2005-08-26 | Combinations for the treatment of cancer |
EP06779226A EP1917011A1 (en) | 2005-08-26 | 2006-08-25 | Combinations comprising dmxaa for the treatment of cancer |
RU2008111492/15A RU2404764C2 (en) | 2005-08-26 | 2006-08-25 | Combinations (compositions), including dmxaa for cancer treatment |
CNA2006800404812A CN101309681A (en) | 2005-08-26 | 2006-08-25 | Combinations comprising dmxaa for the treatment of cancer |
PCT/GB2006/003196 WO2007023302A1 (en) | 2005-08-26 | 2006-08-25 | Combinations comprising dmxaa for the treatment of cancer |
CA002620436A CA2620436A1 (en) | 2005-08-26 | 2006-08-25 | Combinations comprising dmxaa for the treatment of cancer |
AU2006283371A AU2006283371A1 (en) | 2005-08-26 | 2006-08-25 | Combinations comprising DMXAA for the treatment of cancer |
US12/064,633 US20100297112A1 (en) | 2005-08-26 | 2006-08-25 | Combinations comprising dmxaa for the treatment of cancer |
BRPI0614965A BRPI0614965A2 (en) | 2005-08-26 | 2006-08-25 | method for modulating neoplastic growth, uses of a compound or a pharmaceutically acceptable salt, ester or prodrug thereof, a vascular endothelial growth factor binder, and a taxane, pharmaceutical formulation, and kit |
JP2008527517A JP2009506019A (en) | 2005-08-26 | 2006-08-25 | Combinations for cancer treatment |
KR1020087006684A KR20080047402A (en) | 2005-08-26 | 2006-08-25 | Combinations comprising dmxaa for the treatment of cancer |
NO20080649A NO20080649L (en) | 2005-08-26 | 2008-02-06 | Compounds comprising DMXAA for the treatment of cancer |
TNP2008000056A TNSN08056A1 (en) | 2005-08-26 | 2008-02-06 | Combinations comprising dmxaa for the treatment of cancer |
IL189376A IL189376A0 (en) | 2005-08-26 | 2008-02-07 | Combinations comprising dmxaa for the treatment of cancer |
EC2008008243A ECSP088243A (en) | 2005-08-26 | 2008-03-05 | COMBINATIONS UNDERSTANDING DMXAA FOR CANCER TREATMENT |
MA30756A MA29786B1 (en) | 2005-08-26 | 2008-03-17 | COMBINATIONS FOR THE TREATMENT OF CANCER |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0517386A GB0517386D0 (en) | 2005-08-26 | 2005-08-26 | Combinations for the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0517386D0 true GB0517386D0 (en) | 2005-10-05 |
Family
ID=35198383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0517386A Ceased GB0517386D0 (en) | 2005-08-26 | 2005-08-26 | Combinations for the treatment of cancer |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101309681A (en) |
GB (1) | GB0517386D0 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109223764B (en) * | 2018-11-19 | 2021-01-26 | 上海市第一人民医院 | Application of DMXAA in preparation of hypoglycemic drugs |
-
2005
- 2005-08-26 GB GB0517386A patent/GB0517386D0/en not_active Ceased
-
2006
- 2006-08-25 CN CNA2006800404812A patent/CN101309681A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN101309681A (en) | 2008-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL188746A0 (en) | Treatment of cancer | |
IL191832A0 (en) | Pyridiazinone derivatives for the treatment of tumours | |
IL188430A0 (en) | Treatment of tumors | |
EP1830847A4 (en) | Treatment for cancer | |
HK1117780A1 (en) | Compounds and methods for the treatment of cancer | |
AU2006251167A8 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
AU2006251169A8 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
GB0517387D0 (en) | Combinations for the treatment of cancer | |
IL189376A0 (en) | Combinations comprising dmxaa for the treatment of cancer | |
GB0803521D0 (en) | A pharmaceutcal composition useful for the treatment of prostate cancer | |
EP1904088A4 (en) | Compositions and methods for the treatment of cancer | |
GB0428187D0 (en) | Cancer treatment | |
GB0511769D0 (en) | Treatment | |
IL187792A0 (en) | 4-anilino-3-quinolinecarbonitriles for the treatment of cancer | |
GB0520067D0 (en) | Treatment of cancer | |
IL226362A0 (en) | Compounds, and methods for the treatment of cancer | |
ZA200805522B (en) | Dioxoiane dérivates for the treatment of cancer | |
GB0525535D0 (en) | Tumour treatment | |
GB0507685D0 (en) | Cancer treatment | |
ZA200706871B (en) | Treatment of metastasized tumors | |
GB0517386D0 (en) | Combinations for the treatment of cancer | |
GB0404675D0 (en) | Cancer treatment | |
GB0710871D0 (en) | Cancer treatment | |
GB0604114D0 (en) | Combinations for the treatment of cancer | |
GB0503566D0 (en) | Treatment for cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |